Autologous Blood Transfusion Clinical Trial
Official title:
Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University
Perioperative blood loss continues to be a serious problem in complex aortic arch surgery
using deep hypothermic circulatory arrest (DHCA). Major blood loss causes increased
morbidity and mortality [1]. These patients often require transfusion of allogeneic blood
products. It has been estimated shortages of blood supply in China will worsen [2].
Clinicians have made significant progress to decrease the quality of allogenic blood
transfusion.
Increasing postoperative hemorrhage risk of aortic arch patients undergoing DHCA may be
related to CPB induced hemostatic defect, the use of the CPB is likely to contribute to
coagulation factor lost and platelet dysfunction [3, 4]. We are aware of the potential
benefit of aPRP, withdrawal of aPRP immediately before initiating CPB appears to be a
promising approach because it avoids CPB-related platelet damage and limits post-CPB blood
loss. So we adopted and used aPRP as a blood conservation technique to reduce blood
transfusion in aortic arch surgery with DHCA. Autologous red blood cells were infused to
maintain a HGB level above 100 g/L after heparin neutralizing activity. And aPRPs were
transfused after heparin neutralizing activity as no active bleeding was observed. Our goal
was to determine the effect between aPRP and homologous transfusion on perioperative
bleeding during complex aortic arch surgery using DHCA.
1. Patient selection 42 type A aortic dissections patients were asked to participate in a
prospective, randomized trial comparing aPRP technique with regular blood conservation.
6 patients were excluded The patients were randomized into two groups: regular blood
conservation group(n=18) and aPRP group(n=18). Patients gave informed consent, and
ethical permission was approved by the Human Ethics Committee of Beijing Anzhen
Hospital. The grouping situation is blinded to the surgeon, perfusionist and
statistician.
2. Anesthesia and monitoring method All patients were monitored according to the American
Society of Anesthesia guidelines and received standard general anesthesia. A
post-operative analgesic pump was used until four days after surgery. The same group of
surgeons performed all operations. Extracorporeal circulation used DHCA and axillary
arterial anterograde cerebral perfusion. In addition, the same group of physicians
managed extracorporeal circulation.
3. Autologous Platelet-Rich Plasma Harvest Technique In the treatment group, shortly after
administration of general anesthesia, blood was collected via central venous catheter
60 ml per minute (that was proven to be safe) and approximately 15-20 mL/kg of whole
blood was collected. The harvested blood was then centrifuged at 2400 rpm to separate
the red blood cells (RBC) from the autologous platelet rich plasma (aPRP). The
separated blood component was processed by acid sodium citrate glucose solution (AcD-A)
for anti-coagulation. No systemic heparin was administered at this time. The aPRP
component was then stored at 20℃ - 24℃. When the blood withdrawal was proceeding,
lactated ringer's solution and succinylated gelatin were used via the peripheral vein
to dilate circulating capacity and maintain hemodynamic stability. A vasoactive drug
was used if necessary. The systematic heparinization began after blood collection had
completed. General blood salvage was performed during surgery and transfused according
to the patient's actual intraoperative needs.
The mean quantity of whole blood collected for Autologous Platelet-Rich Plasma Harvest
was 1037 ± 286 mL. The control group was only subjected to general intraoperative blood
conservation using red blood cell salvage and allogenic blood transfusion.
4. Transfusion Practice Autologous red blood cells were infused to maintain the HGB level
above 100 g/L. While on CPB, the hemoglobin (HGB) level was maintained between 70 g/L
to 90 g/L. Salvaged blood was also used following CPB. FFP, platelets, and aPRP were
transfused after protamine reversed heparinization, since no active bleeding was
observed. Therapeutic transfusion triggers were: INR TEG-R>11 min for FFP
administration; TEG-a <63 degrees for human fibrinogen; and TEG-MA <52 mm for
aphaeresis platelets
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04496700 -
Transfusion of Whole Blood to Military Forces in a Combat Situation
|
N/A | |
Not yet recruiting |
NCT06244264 -
The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
|
N/A | |
Completed |
NCT05539846 -
Explore the Feasibility of Modified Blood Collection Method
|
N/A |